Ocera Therapeutics, Inc. was a big mover last session, as the company saw its shares rise almost 9%. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company, as the stock is now up 27.51% in the past one-month time frame.
The company has not seen any estimate revision in the past month and its Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
OCRX currently carries a Zacks Rank #2 (Buy), while its Earnings ESP is 0.00%.
A better-ranked stock in the biotechnology industry is Achillion Pharmaceuticals, Inc. (ACHN - Free Report) , holding a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is OCRX going up? Or down? Predict to see what others think: Up or Down
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>